Cargando…

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values

BACKGROUND: Chronic obstructive pulmonary disease (COPD) can affect cognition. The effects of other less severe chronic airway disorders on cognition remain to be clarified. This study aimed to measure and compare cognitive deterioration in subjects with COPD, subjects with chronic non-obstructive b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Negro, Roberto W, Bonadiman, Luca, Tognella, Silvia, Bricolo, Fernanda P, Turco, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085326/ https://www.ncbi.nlm.nih.gov/pubmed/25061286 http://dx.doi.org/10.2147/COPD.S63485

Ejemplares similares

Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT)
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
por: Dal Negro, Roberto W, et al.
Publicado: (2012)

Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD)
por: Casara, Alvise, et al.
Publicado: (2022)

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers
por: Sansores, Raúl H, et al.
Publicado: (2015)

Systemic Galectin-3 in Smokers with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis: The Impact of Exacerbations
por: Sundqvist, Martina, et al.
Publicado: (2021)

Effectiveness of individual counseling for smoking cessation in smokers with chronic obstructive pulmonary disease and asymptomatic smokers
por: CHEN, JUAN, et al.
Publicado: (2014)

Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease
por: Lee, Jin Hwa, et al.
Publicado: (2014)

Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease
por: Lahousse, Lies, et al.
Publicado: (2017)

Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study
por: Negro, Roberto W Dal, et al.
Publicado: (2014)

Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers
por: Willemse, Brigitte WM, et al.
Publicado: (2005)

Comparison of clinical characteristics between chronic bronchitis and non-chronic bronchitis in patients with chronic obstructive pulmonary disease
por: Choi, Joon Young, et al.
Publicado: (2022)

Chronic Bronchitis and Current Smoking Are Associated with More Goblet Cells in Moderate to Severe COPD and Smokers without Airflow Obstruction
por: Kim, Victor, et al.
Publicado: (2015)

Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)

Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease
por: Kim, Victor, et al.
Publicado: (2021)

Efficacy and Safety of N-Acetylcysteine for Chronic Obstructive Pulmonary Disease and Chronic Bronchitis
por: Zhang, Li, et al.
Publicado: (2022)

The prevalence of chronic obstructive pulmonary disease in hookah smokers
por: Bahtouee, Mehrzad, et al.
Publicado: (2017)

Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
por: Rovina, Nikoletta, et al.
Publicado: (2007)

Editorial: Comparison of lung cancer and chronic obstructive pulmonary disease in smokers and never-smokers
por: Kuśnierczyk, Piotr, et al.
Publicado: (2023)

FUMEPOC: Early detection of chronic obstructive pulmonary disease in smokers
por: Gil-Guillén, Vicente, et al.
Publicado: (2011)

Prevalence of different comorbidities in COPD patients by gender and GOLD stage
por: Dal Negro, R. W., et al.
Publicado: (2015)

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Chronic obstructive pulmonary disease in non-smokers - Is it a different phenotype?
por: Jindal, Surinder K.
Publicado: (2018)

Solid Fuel Exposure and Chronic Obstructive Pulmonary Disease in Never-Smokers
por: Long, HuanYu, et al.
Publicado: (2021)

Association Between Non-obstructive Chronic Bronchitis and Incident Chronic Obstructive Pulmonary Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis
por: Wu, Fan, et al.
Publicado: (2022)

Effect of myrtol on chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Liu, Liyun, et al.
Publicado: (2020)

Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: a systematic review and meta-analysis
por: Jarhyan, Prashant, et al.
Publicado: (2022)

Prevalence of Chronic Obstructive Pulmonary Disease and Chronic Bronchitis Among Predominantly Smoking Workers in the Seafood Industry in Greenland
por: Frederiksen, Anja Lærke, et al.
Publicado: (2022)

The Global Usability Score Short-Form for the simplified assessment of dry powder inhalers (DPIs) usability
por: Povero, Massimiliano, et al.
Publicado: (2020)

Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease
por: Peltoniemi, Mirva J, et al.
Publicado: (2006)

Genetic Determinants of Chronic Obstructive Pulmonary Disease in South Indian Male Smokers
por: Arja, Cholendra, et al.
Publicado: (2014)

Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey
por: Mun, So Yeong, et al.
Publicado: (2015)

Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea
por: Lee, Seok Jeong, et al.
Publicado: (2015)

Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease
por: Rigden, Helen M., et al.
Publicado: (2016)

The clinical efficacy of AG NPP709 (Synatura(®)) in patients with chronic bronchitis type stable chronic obstructive pulmonary disease
por: Lee, Eung Gu, et al.
Publicado: (2020)

Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study
por: Truedsson, Mikael, et al.
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients: A meta-analysis and system review
por: Wu, Jian-Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oqp7don2cemkmpjuaqev2v0gnp